Rhumbline Advisers Conformis Inc Transaction History

Rhumbline Advisers

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$0.59 - $1.12 $33,530 - $63,651	-56,832 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$1.45 - $2.55 $1,271 - $2,236	877 Added 1.57%	56,832 $85,000
Q3 2019 Oct 23, 2019	SELL	$1.49 - $4.12 $461 - $1,277	-310 Reduced 0.55%	55,955 $104,000
Q2 2019 Aug 14, 2019	BUY	$2.11 - $4.71 $118,719 - $265,008	56,265 New	56,265 $245,000
Q2 2018 Aug 06, 2018	SELL	$1.22 - $1.79 $48,635 - $71,358	-39,865 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$1.2 - $2.62 $780 - $1,703	650 Added 1.66%	39,865 $58,000
Q4 2017 Feb 09, 2018	SELL	$2.24 - $4.13 $13,254 - $24,437	-5,917 Reduced 13.11%	39,215 $93,000
Q3 2017 Nov 06, 2017	BUY	$3.35 - $3.96 $151,192 - $178,722	45,132	45,132 $159,000

5.79K

Ticker CFMS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 187,856,992
Description
Conformis, Inc., a medical technology company, develops, manufactures, and sells patient-specific products and instrumentation. The company offers personalized knee replacement products, including iUni, iDuo, a custom-made partial knee replacement option for either unicompartmental or bicompartmental osteoarthritis of the knee; iTotal CR, a cruc...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.